Previous Article
Biosimilars in the time of COVID-19 and beyond
Biosimilars in the time of COVID-19 and beyond

Introduction The recent COVID-19 pandemic has triggered a race for pharmaceutical companies to repurpose...

Next Article
Understanding the COVID-19 regulatory procedures the FDA is using
Understanding the COVID-19 regulatory procedures the FDA is using

A diagram that shows various procedural steps when interacting with the FDA through CTAP.